Ergoteles LLC Durect Corp Transaction History

Ergoteles LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.43 - $5.9 $32,658 - $448,105	-75,950 Reduced 7.57%	928,000 $537,000
Q2 2022 Aug 12, 2022	BUY	$0.38 - $0.64 $381,501 - $642,528	1,003,950 New	1,003,950 $480,000
Q1 2022 May 13, 2022	SELL	$0.55 - $0.98 $7,671 - $13,670	-13,949 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.9 - $1.31 $22,005 - $32,030	-24,451 Reduced 63.67%	13,949 $14,000
Q3 2021 Nov 15, 2021	BUY	$1.21 - $1.61 $4,598 - $6,118	3,800 Added 10.98%	38,400 $49,000
Q2 2021 Aug 12, 2021	BUY	$1.6 - $2.02 $55,360 - $69,892	34,600 New	34,600 $56,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $216M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.